<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">NSS</journal-id>
      <journal-id journal-id-type="pmc">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">31692507</article-id>
      <article-id pub-id-type="pmc">6707934</article-id>
      <article-id pub-id-type="publisher-id">182158</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S182158</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Impact of traumatic brain injury on sleep: an overview</article-title>
        <alt-title alt-title-type="running-authors">Aoun et al</alt-title>
        <alt-title alt-title-type="running-title">Aoun et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aoun</surname>
            <given-names>Raissa</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rawal</surname>
            <given-names>Himanshu</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Attarian</surname>
            <given-names>Hrayr</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0003">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sahni</surname>
            <given-names>Ashima</given-names>
          </name>
          <xref ref-type="corresp" rid="AN0001"/>
          <xref ref-type="aff" rid="AFF0004">4</xref>
        </contrib>
        <aff id="AFF0001"><label>1</label><institution>Department of Neurology, Lebanese American University Medical Center – Rizk Hospital</institution>, <addr-line>Beirut</addr-line>, <country>Lebanon</country></aff>
        <aff id="AFF0002"><label>2</label><institution>Department of Medicine, Medstar Union Memorial Hospital</institution>, <addr-line>Baltimore</addr-line>, <addr-line>MD</addr-line>, <country>USA</country></aff>
        <aff id="AFF0003"><label>3</label><institution>Department of Neurology, Northwestern Memorial Hospital</institution>, <addr-line>Chicago</addr-line>, <addr-line>IL</addr-line>, <country>USA</country></aff>
        <aff id="AFF0004"><label>4</label><institution>Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago</institution>, <addr-line>IL</addr-line>, <addr-line>Chicago</addr-line>, <country>USA</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="AN0001">Correspondence: Ashima Sahni<institution>Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago (MC 719)</institution>, <addr-line>Chicago</addr-line>, <addr-line>IL</addr-line><addr-line>60612</addr-line>, <country>USA</country><phone>Tel +312 355 4806</phone>Email asahni@uic.edu</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>8</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2019</year>
      </pub-date>
      <volume>11</volume>
      <fpage>131</fpage>
      <lpage>140</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>5</month>
          <year>2019</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>8</month>
          <year>2019</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2019 Aoun et al.</copyright-statement>
        <copyright-year>2019</copyright-year>
        <copyright-holder>Aoun et al.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p><citation_analysis attribute="negative">Traumatic brain injury (TBI) is a global health problem that affects millions of civilians, athletes, and military personnel yearly. Sleeping disorders are one of the underrecognized sequalae even though they affect 46% of individuals with TBI. After a mild TBI, 29% of patients have insomnia, 25% have sleep apnea, 28% have hypersomnia, and 4% have narcolepsy. The type of sleep disturbance may also vary according to the number of TBIs sustained. Diffuse axonal injury within the sleep regulation system, disruption of hormones involved in sleep, and insults to the hypothalamus, brain stem, and reticular activating system are some of the proposed theories for the pathophysiology of sleep disorders after TBI. Genetic and anatomical factors also come to play in the development and severity of these sleeping disorders. Untreated sleep disturbances following TBI can lead to serious consequences with respect to an individual’s cognitive functioning. Initial management focuses on conservative measures with progression to more aggressive options if necessary. Future research should attempt to establish the effectiveness of the treatments currently used, as well as identify manageable co-existing factors that could be exacerbating sleep disorders.</citation_analysis></p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>traumatic brain injury</kwd>
        <kwd>neurobiology</kwd>
        <kwd>sleep disorders</kwd>
        <kwd>TBI</kwd>
        <kwd>sleep</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="2"/>
        <ref-count count="46"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Traumatic brain injury (TBI) is defined as a disruption in brain function due to the impact of contact forces including rapid acceleration, deceleration, or collision, manifesting as altered state of consciousness, neurological deficits, and/or amnesia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> It is classified as mild, moderate, or severe depending on the presence and duration of the symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="positive"> TBI is a significant public health problem affecting civilians, athletes, and military personnel as a result of motor vehicle accidents, falls, contact sports, assaults, and explosions.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> Over the years, the rates of TBI in the US population have increased with more emergency room visits, driving the health care costs, though the rate of hospitalization and deaths has been steady.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> In fact, it is estimated that 1.5 million people in the US suffer a brain injury every year. Approximately, 80% of these injuries are classified as mild in severity.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Mild TBI (mTBI), the most common form of TBI in high-impact sports,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> can lead to a wide array of cognitive, emotional, and somatic symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="positive"> The most frequently reported symptoms include fatigue, headaches, memory impairment, concentration deficits, and sleep-related problems.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> The majority of patients achieve complete resolution of symptoms quickly after a mTBI, but 10–20% may develop persisting symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="negative"> In fact, neuropsychological testing revealed persistent cognitive impairments in boxers following mTBI extending beyond the subjectively symptomatic period.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0006" ref-type="bibr">6</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Sleep disorders are underrecognized consequences of TBI despite their high prevalence. In general, around 46% of individuals have sleep disorders following TBI including sleep apnea, insomnia, post-traumatic hypersomnia, and narcolepsy.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">It is important to recognize and manage sleep disorders in TBI patients because untreated sleep disturbances translate to longer hospital stays, higher cost of rehabilitation, and more disability.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The aim of this review is to discuss the pathophysiology of sleep disturbances after TBI, the various sleep disorders encountered, their management, and future directions.</citation_analysis></p>
    </sec>
    <sec id="S0002">
      <title>Neurobiology of sleep</title>
      <p><citation_analysis attribute="neither">The suprachiasmatic nucleus in the hypothalamus is the master regulator of circadian rhythms. A cluster of neurons, known as the reticular activating system (RAS), expand into the hypothalamus from the tegmentum of the brainstem and play a crucial role in maintaining arousal. The network of neurons in the RAS process information from multiple projections in the brain through neurotransmitters and neuromodulations to control sleep and wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0004" ref-type="bibr">4</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">There are three distinct states of being: wakefulness, rapid eye movement sleep (REM) and non-rapid eye movement sleep (NREM). Monoaminergic and cholinergic system are predominantly wake-promoting systems, which also receive excitatory hypothalamic hypocretin/orexin input to promote wakefulness. GABAergic system is the important sleep-promoting system and is present in the brainstem, lateral hypothalamus, and preoptic area. REM sleep is primarily generated in the dorsolateral pons. Cholinergic activation promotes and maintains REM sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0009" ref-type="bibr">9</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Sleep and wakefulness is a fine interplay between the homeostatic and circadian drive. Homeostatic drive is also called sleep drive, which increases continually during wakefulness and is reduced by sleeping. This drive is primarily regulated by adenosine through a partially understood mechanism that involves cortical neuronal nitric oxide (nNOS) neurons and neurokinin 1 receptors.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> On the other hand, the circadian rhythm is the alerting process driven by suprachiasmatic nuclei in the hypothalamus. It naturally dips in the late afternoon but is high during the day and low during the night. It is primarily regulated through the light-induced suppression and darkness-induced release of the pineal neurohormone melatonin.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither"> The integration of the two drives also takes place in the suprachiasmatic nucleus and may involve orexin A/hypocretin 1 input.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0012" ref-type="bibr">12</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Other neuropeptides involved in sleep–wake regulation include pituitary hormones, cytokines interleukin-1, interleukin-6, and tumor necrosis factor alpha</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither"> as well as melanin-concentrating hormone (MCH). MCH coexists with GABA in hypothalamic neurons involved in REM control.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0014" ref-type="bibr">14</xref></citation_analysis></p>
    </sec>
    <sec id="S0003">
      <title>Pathophysiology of sleep disturbance after TBI</title>
      <sec id="S0003-S2001">
        <title>Direct factors</title>
        <p><citation_analysis attribute="positive">Several theories have been proposed for the pathophysiology of sleep disorders after TBI. Diffuse axonal injury (DAI) occurring within the arousal and/or sleep regulation system has been implicated as a possible cause.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> DAI can occur across the spectrum of TBI severity and is considered the most important factor in determining morbidity in TBI patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> DAI leads to impairment in axonal membrane stability and intracellular function which results in signal disruption and accumulation of proteinaceous waste products</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">.1</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, the ruptured cell membranes release glutamate which provokes a toxic metabolic cascade of cell injury leading to acidosis and edema.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0018" ref-type="bibr">18</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Disruption of hormonal systems involved in sleep is another implicated cause of sleep disturbance after TBI. In research studies, TBI groups were found to have decreased levels of hypocretin, histamine, and melatonin in the CSF.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> Hypocretin and histamine are wake-promoting neurotransmitters; therefore, low CSF levels of these two are associated with hypersomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> On the other hand, reduced melatonin is associated with decreased REM sleep in TBI.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> Studies showed that 95% of patients with acute TBI had low CSF hypocretin (less than 320 pg/mL),</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> and autopsies of individuals who died from severe TBI showed a 41% reduction of histaminergic neurons in the tuberomammillary nucleus of the hypothalamus.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Insults to key brain regions involved in sleep such as the hypothalamus, brain stem, and RAS also underpin sleep disturbances in TBI patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> Damage to the retino-hypothalamic tract, which coordinates the hypothalamic circadian pacemaker with the light–dark cycle, can lead to abnormally programmed circadian rhythms.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="positive"> Post-TBI animal models also show impairment in the expression of BMAL1 and Cry 1 genes indicating disruption in the circadian rhythm.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0021" ref-type="bibr">21</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">There are also genetic factors that come to play in the development of sleeping disorders in mTBI patients. Per3 is one of the many polymorphic genes that are involved in the regulation of the circadian rhythm. Studies showed that carriers of Per3 have a shorter duration of sleep at 6 weeks post mTBI compared to baseline, and only Per3 noncarriers showed improvement in sleep quality with time.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">In addition, some craniofacial phenotypes may be particularly vulnerable to the development or worsening of sleep disorders. In acceleration–deceleration injuries, variations in the structure of the tentorial notch may impact the level of brainstem distortion. Also, people with certain anatomical features may be more prone to injure the pineal gland, resulting in dysregulation of melatonin homeostasis. This impairs adequate circadian activity and leads to sleep disturbances.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> Sleep-disordered breathing such as obstructive sleep apnea can also be a consequence of injury to upper respiratory muscles along with TBI. Supine sleep, weight gain, and medication – induced reduced muscle tone and respiratory depression further contribute to sleep-disordered breathing in TBI patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis></p>
      </sec>
      <sec id="S0003-S2002">
        <title>Indirect factors</title>
        <p><citation_analysis attribute="neither">It is important to acknowledge the contribution of secondary factors like fatigue and depression after TBI to the development of sleep disturbances.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> Generalized anxiety disorder within 3 months of TBI has been consistently correlated to onset of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="positive"> Moreover, people with TBI tend to use more medications than the general population such as antidepressants, analgesics, and sedative-hypnotics which can add to the sleep deficits observed.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> Other secondary complications following TBI, such as medical comorbidities, may also play a role in sleeping difficulties.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis></p>
        <p><citation_analysis attribute="negative">To conclude, taken together, the risk for sleep disturbances in a patient with TBI is the product of several internal and external influences, all acting on a genetically determined substrate.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> Untreated sleep disturbances following TBI can lead to potentiation of the injury at cellular level, leading to cognitive dysfunction: Sleep is essential for the optimal functioning of the glymphatic system, which is the waste clearance pathway of the central nervous system.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> Therefore, sleep disruption may lead to reduced clearance and subsequently increased accumulation of proteinaceous waste products like p-tau and beta-amyloid. Also, in TBI patients, resulting astroglial scars and inflammation may further the damage to the glymphatic system and increase the buildup of these neurotoxins. Persistent accumulation of waste products may potentiate neurodegenerative processes like Alzheimer’s disease and chronic traumatic encephalopathy.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0018" ref-type="bibr">18</xref></citation_analysis></p>
      </sec>
    </sec>
    <sec id="S0004">
      <title>Various sleep disorders encountered in TBI</title>
      <p><citation_analysis attribute="positive">Studies have shown that mild TBI is more strongly associated with sleep disturbances than moderate to severe TBI.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="positive"> This may be because individuals with mild TBI are more likely to report sleep disturbances than people with severe TBI who perceive sleep disturbances as minor compared to other cognitive sequelae.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> However, research has also proposed that the location of the lesion is more important than the severity of TBI in predicting sleep outcomes, where damage to the arousal/sleep regulation centers causes the most sleep disturbances.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Nearly 50% of patients report sleep disturbances after injury (Table1). Actigraphy and polysomnography, which are objective measures of sleep, verify the subjective complaints reported.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="positive"> A meta-analysis reported that after a TBI, 29% of patients have insomnia, 25% have sleep apnea, 28% have hypersomnia, and 4% have narcolepsy.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis></p>
      <p><citation_analysis attribute="negative">Acutely after a TBI, individuals can experience early phase symptoms like headaches, fatigue, amnesia, and sleep disruption. These symptoms resolve over a few weeks in the majority of people. However, 10–15% develop prolonged symptoms that affect the quality of life.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="positive"> Studies have shown that individuals with TBI have longer sleep onset latencies, shorter total duration of sleep, and more nighttime awakenings than controls. Also, TBI patients were found to spend less time in REM sleep. They report poor sleep quality, more daytime dysfunction, and the use of more sleep medication. This was corroborated by objective sleep measures like the Epworth Sleepiness Scale and PSQI.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The type of sleep disturbance might vary according to the number of TBIs. Following a first TBI, the most commonly reported complaint is onset insomnia. Following an additional TBI, maintenance insomnia intensifies.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="positive"> In military personnel, the number of lifetime TBIs was found to be a significant predictor of insomnia severity even when controlling for depression, PTSD, and severity of concussion symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="positive"> In fact, insomnia is one of the most commonly reported symptoms among patients with TBI, and it is the second most documented sleep disturbance in people with TBI, after snoring.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> Prevalence rates of insomnia, which are estimated to range from 6% to 10% of the general population, reach 25–29% in patients with TBI.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In a prospective study, TBI patients were recruited from rehabilitation facilities and underwent sleep studies at least 3 months post-injury. 6% of the TBI patients met the diagnostic criteria for narcolepsy, which is significantly higher than the prevalence of the diseases in the general population (0.056%).</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> The prevalence of sleep-disordered breathing in TBI patients was found to be 23% which is also significantly higher than the general population. In rehabilitation centers, parasomnias – most commonly REM sleep behavior disorder – were the presenting complaint in 25% of patients with brain trauma.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Increased sleep need after mTBI, also known as post-traumatic hypersomnia, affects around 20% of individuals after brain injury. It manifests as fatigue, longer sleep durations, or excessive daytime sleepiness. Several notions have been proposed as causative factors. The first hypothesis is that persistent pain is an important cause for both the development and maintenance of excessive sleep need.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> Decreased quality of life due to pain was significantly associated with sleep need exceeding eight hours per day as well as increased number of naps.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> This is because patients with pain were found to have increased ß power frequency – brain waves associated with active thinking and concentration – in the prefrontal and frontal cortices during NREM and REM sleep compared to mTBI patients with no pain, which could cause a relative state of “arousal” even when asleep. This impedes the restorative function of sleep leading to increased sleep need to compensate. Another hypothesis implicated the hypocretin system in the development of increased sleep need after brain injury. As mentioned previously, low levels of hypocretin have been found in the CSF of most TBI patients, which can explain increased sleepiness.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0025" ref-type="bibr">25</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Untreated sleep disorders impact sleep architecture. Moderate to severe TBI is characterized by increased slow wave sleep (SWS) and reduced stage 2 sleep, reflecting cortical reorganization and restructuring after injury. These alterations in sleep architecture have not been observed in mild TBI.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> Both obstructive sleep apnea and insomnia patients have reduced REM and slow wave sleep, but these tend to normalize with effective treatment.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis></p>
    </sec>
    <sec id="S0005">
      <title>Impact on quality of life</title>
      <p><citation_analysis attribute="neither">Sleep disorders significantly impact quality of life and contribute to disability. Inadequate sleep can negatively affect rehabilitation and optimal recovery in inpatients with TBI, leading to poorer outcomes and cognitive dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="positive"> Moreover, insomnia has been associated with increased disability and delayed recovery from brain injury in workers independent of age, gender, and other psychiatric co-morbidities. This was determined using the Sheehan disability scale (SDS), which measures items pertaining to impairment in work, social life, and family responsibilities.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> This emphasizes the importance of identifying and treating sleep disorders to improve quality of life and work-related outcomes.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0004" ref-type="bibr">4</xref></citation_analysis></p>
    </sec>
    <sec id="S0006">
      <title>Diagnosis</title>
      <p><citation_analysis attribute="neither">It is important to start by ruling out modifiable causes of sleep disturbances like pain, bowel/bladder issues, and mood disturbances.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Adequate management starts with accurate diagnosis. Subjective sleep symptoms in TBI patients can be unreliable; therefore, objective testing with polysomnography and MSLT are essential to diagnose sleep disorders like sleep apnea, narcolepsy, and post-traumatic hypersomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> Actigraphy and sleep logs at home over several nights are also good ways of assessing sleep after TBI.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> The sleep lab can create a new and confounding environment for the individual, which makes actigraphy a useful alternative since it assesses sleep at home over several nights.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0015" ref-type="bibr">15</xref></citation_analysis></p>
    </sec>
    <sec id="S0007">
      <title>Management</title>
      <sec id="S0007-S2001">
        <title>Conservative management</title>
        <p><citation_analysis attribute="neither">Initial management should focus on conservative measures with progression to more aggressive options if necessary.</citation_analysis></p>
        <sec id="S0007-S2001-S3001">
          <title>Sleep hygiene</title>
          <p><citation_analysis attribute="neither">Sleep hygiene is the first factor to address, including avoiding stimulating activities before bed, fixed schedules, and avoiding late afternoon caffeine and alcohol. If the patient is not asleep within 30 mins of being in bed, he or she should engage in any stimulating activity in another room and return to bed only when drowsy.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="positive"> Regular aerobic exercise has also been shown to improve sleep quality in TBI patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis></p>
          <p><citation_analysis attribute="positive">Cognitive behavioral therapy (CBT) is also a technique that helps alter a patient’s negative associations with sleep. Examples include relaxation training and CBT.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> CBT for insomnia (CBTi) is considered the first-line approach for management of insomnia. It works by targeting and altering dysfunctional beliefs and attitudes about sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="positive"> It is associated with increased total sleep time and decreased sleep–onset latency as evidenced by objective sleep measurements like actigraphy and polysomnography,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> and it has been found to be superior to pharmacological therapy.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis></p>
        </sec>
        <sec id="S0007-S2001-S3002">
          <title>Phototherapy or light exposure</title>
          <p><citation_analysis attribute="neither">A study also looked into the effect of ocular light exposure as a stimulant in the TBI population, and it showed reduced fatigue and daytime sleepiness with blue light therapy compared with the use of modafinil for 6 weeks.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> Some patients with TBI are very sensitive to light; therefore, avoidance of full spectrum bright light is advised.</citation_analysis></p>
        </sec>
        <sec id="S0007-S2001-S3003">
          <title>Other non-pharmacotherapies</title>
          <p><citation_analysis attribute="neither">Osteopathic manipulative treatments (craniosacral therapy, visceral and neural manipulation) as well acupuncture also showed benefits in sleep quality for TBI patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis></p>
        </sec>
      </sec>
      <sec id="S0007-S2002">
        <title>Pharmacotherapy</title>
        <p><citation_analysis attribute="positive">Pharmacotherapy should be initially attempted as a short-term treatment using the lowest effective dose and intermittently to avoid tolerance and dependence.</citation_analysis></p>
        <p><citation_analysis attribute="neither">Pharmacotherapy is divided into three categories based on the predominant sleep symptomatology.</citation_analysis></p>
      </sec>
      <sec id="S0007-S2003">
        <title>Insomnia</title>
        <p><citation_analysis attribute="neither">A commonly used drug to treat insomnia after head injury is trazodone, an antidepressant with both sedative and anxiolytic properties.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> Zolpidem, zaleplon, zopiclone, and eszopiclone are also non-benzodiazepine hypnotics that are frequently used.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> Common interventions used for insomnia are summarized in </citation_analysis><citation_analysis attribute="positive"><xref rid="T0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="positive">. If insomnia is due to PTSD, studies on veterans with mild TBI have shown that prazosin, a selective α-1 receptor antagonist, improves symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="positive"><table-wrap id="T0001" orientation="landscape" position="float"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Summary of sleep disorders in TBI patients and their management</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Disorders</th><th rowspan="1" colspan="1">Pathogenesis</th><th rowspan="1" colspan="1">Diagnosis</th><th rowspan="1" colspan="1">Management</th><th rowspan="1" colspan="1">Prognosis</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Insomnia<xref rid="CIT0037" ref-type="bibr">37</xref></td><td rowspan="1" colspan="1">Trauma to inferior frontal and anterior temporal lobes.<break/>Increased sensitivity to noise and light (paroxysmal sympathetic hyperactivity).<xref rid="CIT0036" ref-type="bibr">36</xref><break/>Psychological insult due to injury.<break/>Generalized anxiety.</td><td rowspan="1" colspan="1">History<break/>actigraphy</td><td rowspan="1" colspan="1">Ramelteon<break/>Caution with benzodiazepines (BZD) and non-BZDs due to cognitive impairment.<break/>Anti-depressants if the patient has co-morbid depression.<break/>Cognitive behavioral therapy (CBTI).<break/>Co-morbid PTSD – prazosin + CBTI<break/>Acupunture<break/><xref rid="T0002" ref-type="table">Table 2</xref></td><td rowspan="1" colspan="1">Associated with mild TBI<break/>Worse health outcomes</td></tr><tr><td rowspan="1" colspan="1">Post-traumatic hypersomnia/narcolepsy<xref rid="CIT0038" ref-type="bibr">38</xref></td><td rowspan="1" colspan="1">Direct injury to histamine tubero-mammillary neurons</td><td rowspan="1" colspan="1">Polysomnogram (PSG) + MSLT</td><td rowspan="1" colspan="1">Stimulants</td><td rowspan="1" colspan="1">Associated with more severe TBI</td></tr><tr><td rowspan="1" colspan="1">Circadian rhythm disturbances<xref rid="CIT0031" ref-type="bibr">31</xref>,<xref rid="CIT0033" ref-type="bibr">33</xref>,<xref rid="CIT0039" ref-type="bibr">39</xref></td><td rowspan="1" colspan="1">Injury involving hypothamaus/suprachiasmatic nucleus</td><td rowspan="1" colspan="1">Actigraphy/sleep diaries – challenging and limiting due to the disease condition.<break/>Research tools – Salivary melatonin; body temperature monitoring</td><td rowspan="1" colspan="1">Combination or monotherapy of light and melatonin therapy depending on the type of the circadian rhythm disturbance</td><td rowspan="1" colspan="1">If by day 8 patient recovered the sleep/wake pattern – shorter ICU and hospital stay, less amnesia, less disability</td></tr><tr><td rowspan="1" colspan="1">Restless leg syndrome</td><td rowspan="1" colspan="1">Unclear</td><td rowspan="1" colspan="1">Clinical history</td><td rowspan="1" colspan="1">Similar to non-TBI patients</td><td rowspan="1" colspan="1">Contributes to increased fatigue, sleepiness and reduced concentration</td></tr><tr><td rowspan="1" colspan="1">Obstructive sleep apnea<xref rid="CIT0040" ref-type="bibr">40</xref>–<xref rid="CIT0042" ref-type="bibr">42</xref></td><td rowspan="1" colspan="1">Direct injury hypothalamus/satiety center causing weight gain.<break/>Weight gain due to immobilization.<break/>Injury to the upper airway musculature.<break/>Cranial neuropathies.</td><td rowspan="1" colspan="1">Polysomnogram</td><td rowspan="1" colspan="1">CPAP</td><td rowspan="1" colspan="1">If untreated; more memory impairment and concentration/attention</td></tr><tr><td rowspan="1" colspan="1">Central sleep apnea</td><td rowspan="1" colspan="1">Brain stem injury.<break/>Central acting medications – opiates/baclofen</td><td rowspan="1" colspan="1">Polysomnogram</td><td rowspan="1" colspan="1">CPAP/adaptive seroventilation</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></citation_analysis><citation_analysis attribute="positive"><table-wrap id="T0002" orientation="portrait" position="float"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Insomnia management in TBI patients</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Treatment</th><th rowspan="1" colspan="1">Dosage</th><th rowspan="1" colspan="1">Results</th><th rowspan="1" colspan="1">Duration</th><th rowspan="1" colspan="1">Type of study</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Ramelteon<xref rid="CIT0043" ref-type="bibr">43</xref></td><td rowspan="1" colspan="1">8 mg</td><td rowspan="1" colspan="1">Increase in total sleep time<break/>Improvement in executive functioning</td><td rowspan="1" colspan="1">3 weeks</td><td rowspan="1" colspan="1">RCT/Cross cover</td></tr><tr><td rowspan="1" colspan="1">Zopiclone<xref rid="CIT0044" ref-type="bibr">44</xref></td><td rowspan="1" colspan="1">3.75–7.5 mg</td><td rowspan="1" colspan="1">Improvement with no cognitive deficits</td><td rowspan="1" colspan="1">7 days</td><td rowspan="1" colspan="1">RCT</td></tr><tr><td rowspan="1" colspan="1">Lorazepam<xref rid="CIT0044" ref-type="bibr">44</xref></td><td rowspan="1" colspan="1">0.5−1 mg</td><td rowspan="1" colspan="1">Improvement with no cognitive deficits</td><td rowspan="1" colspan="1">7 days</td><td rowspan="1" colspan="1">RCT</td></tr><tr><td rowspan="1" colspan="1">CBT-I<xref rid="CIT0045" ref-type="bibr">45</xref></td><td rowspan="1" colspan="1">6 weeks</td><td rowspan="1" colspan="1">79% of patients improvement</td><td rowspan="1" colspan="1">6 months</td><td rowspan="1" colspan="1">Open label</td></tr><tr><td rowspan="1" colspan="1">Acupuncture<xref rid="CIT0046" ref-type="bibr">46</xref></td><td rowspan="1" colspan="1">10 sessions/5 weeks</td><td rowspan="1" colspan="1">Insomnia severity index improved in intervention arm</td><td rowspan="1" colspan="1">1 month</td><td rowspan="1" colspan="1">RCT</td></tr></tbody></table><table-wrap-foot><fn><p><citation_analysis attribute="positive"><bold>Abbreviation:</bold></citation_analysis><citation_analysis attribute="neither"> RCT, randomized control trial.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="S0007-S2004">
        <title>Post-traumatic hypersomnia/post-traumatic narcolepsy</title>
        <p><citation_analysis attribute="positive">Stimulant therapy would be warranted for post-traumatic hypersomnia. Positive results have been seen with modafinil. Increased aggression was noted in patients after initiation of methylphenidate, but beta blockers have shown some potential in mitigating drug-exacerbated aggression.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0030" ref-type="bibr">30</xref></citation_analysis></p>
      </sec>
      <sec id="S0007-S2005">
        <title>Circadian rhythm disorders</title>
        <p><citation_analysis attribute="positive">Sleep agents like melatonin (0.5–3 mg/night), valerian root (300–600 mg per day), and L-tryptophan have been used, but studies have shown limited effectiveness in the TBI population.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="positive"> In fact, the management of circadian rhythm disorders in TBI is mostly the same as the general population except that prolonged hospitalization, decreased mobility, sedative effects of medications, and tube feeding with no proper light exposure could be challenging.</citation_analysis><citation_analysis attribute="positive"><sup>31</sup></citation_analysis><citation_analysis attribute="neither"> Secondly, the reduction in the intrinsic melatonin secretion in patients with TBI may warrant higher doses of melatonin for management of circadian rhythm disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0032" ref-type="bibr">32</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Revised strategies for managing various circadian rhythm disorders include a combination of light and melatonin therapy.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither"> In patients with advanced sleep–wake phase disorder, light therapy 2 hrs in the evening is recommended. </citation_analysis><citation_analysis attribute="positive"><xref rid="F0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither"> demonstrates both the pretreatment and post-light therapy sleep–wake cycles (</citation_analysis><citation_analysis attribute="positive"><xref rid="F0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">). For delayed sleep–wake phase disorder, melatonin between 0.5–3 mg is recommended 5 hrs before habitual bedtime, as well as light therapy (at least 5000 lux) 30 mins to 2 hrs upon awakening. </citation_analysis><citation_analysis attribute="positive"><xref rid="F0002" ref-type="fig">Figure 2</xref></citation_analysis><citation_analysis attribute="neither"> demonstrates both the pretreatment and post light and melatonin therapy sleep–wake cycles (</citation_analysis><citation_analysis attribute="positive"><xref rid="F0002" ref-type="fig">Figure 2</xref></citation_analysis><citation_analysis attribute="positive">). It is difficult to treat patients with irregular sleep–wake phase disorder, and a trial of melatonin between 0.5 mg and 3 mg is suggested at bedtime, as well as light therapy during daytime along with structured daytime activities. </citation_analysis><citation_analysis attribute="positive"><xref rid="F0003" ref-type="fig">Figure 3</xref></citation_analysis><citation_analysis attribute="neither"> demonstrates both the pretreatment and post-light therapy sleep–wake cycles (</citation_analysis><citation_analysis attribute="positive"><xref rid="F0003" ref-type="fig">Figure 3</xref></citation_analysis><citation_analysis attribute="positive">). For non-4-h sleep–wake phase disorder, management differs between sighted and blind patients. In blind patients, melatonin 0.5 mg or tasimelteon is suggested 1 h before habitual bedtime. In sighted individuals, bright light is recommended upon awakening along with regular sleep–wake schedule with or without melatonin.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0034" ref-type="bibr">34</xref></citation_analysis></p>
      </sec>
      <sec id="S0007-S2006">
        <title>Management of other comorbid sleep disorders</title>
        <sec id="S0007-S2006-S3001">
          <title>Obstructive sleep apnea</title>
          <p><citation_analysis attribute="positive">TBI patients with sleep apnea are treated effectively with continuous positive airway pressure, though cognitive impairment and/or co-morbid post-traumatic stress disorder can be a major hurdle.</citation_analysis></p>
        </sec>
        <sec id="S0007-S2006-S3002">
          <title>Periodic limb movements</title>
          <p><citation_analysis attribute="neither">The patients with periodic movements are well treated with pramipexole at a dose of 0.375 mg/day.</citation_analysis></p>
        </sec>
        <sec id="S0007-S2006-S3003">
          <title>Bruxism (sleep-related teeth grinding)</title>
          <p><citation_analysis attribute="neither">The standard of care is a mouth guard that protects the teeth from the wear and tear of grinding. A single study, however, also showed success in the treatment of bruxism with botulinum toxin in a TBI patient.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis></p>
        </sec>
      </sec>
    </sec>
    <sec id="S0008">
      <title>Future direction</title>
      <p><citation_analysis attribute="neither">Given the importance of early identification and management of sleep disorders in TBI patients, future research should continue to focus on diagnosis and treatment questions. Biomarkers could be established to characterize the presence or absence of brain injury, like protein or neuroimaging markers.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> Emphasis on pain management and further research into its role in the pathophysiology of sleep disturbances is warranted.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> Also, fatigue co-exists with sleep disturbances in most cases and may exacerbate it. Therefore, targeting both fatigue and sleep disturbance in treatment is worth investigating.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="neither"> Finally, more research is needed to establish the effectiveness of various treatment and management approaches in TBI patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis></p>
    </sec>
    <sec id="S0009">
      <title>Conclusion</title>
      <p><citation_analysis attribute="neither">Sleep disorders are common in people who suffer TBIs due to disruption in the arousal/sleep regulation system and hormonal systems. Timely diagnosis and management of these sleep disorders is very important for adequate neuro-recovery. Failure to do so can lead to impaired cognition and quality of life. Management should start with conservative measures such as sleep hygiene and CBT followed by pharmacological agents if the former approaches do not succeed.
</citation_analysis><citation_analysis attribute="positive"><fig id="F0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">Management of advanced sleep–wake phase disorder.</citation_analysis></p></caption><graphic content-type="print-only" xlink:href="NSS-11-131-g0001"/></fig></citation_analysis><citation_analysis attribute="positive"><fig id="F0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p><citation_analysis attribute="neither">Management of delayed sleep–wake phase disorder.</citation_analysis></p></caption><graphic content-type="print-only" xlink:href="NSS-11-131-g0002"/></fig></citation_analysis><citation_analysis attribute="positive"><fig id="F0003" fig-type="figure" orientation="portrait" position="float"><label>Figure 3</label><caption><p><citation_analysis attribute="neither">Management of irregular sleep–wake phase disorder.</citation_analysis></p></caption><graphic content-type="print-only" xlink:href="NSS-11-131-g0003"/></fig></citation_analysis></p>
    </sec>
  </body>
  <back>
    <sec id="S0010" sec-type="COI-statement">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors report no conflicts of interest in this work.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Katz</surname>
<given-names>DI</given-names></string-name>, <string-name><surname>Cohen</surname>
<given-names>SI</given-names></string-name>, <string-name><surname>Alexander</surname>
<given-names>MP</given-names></string-name>. <article-title>Mild traumatic brain injury</article-title>. <source><italic toggle="yes">Handb Clin Neurol</italic></source>. <year>2015</year>;<volume>127</volume>:<fpage>131</fpage>–<lpage>156</lpage>.<pub-id pub-id-type="pmid">25702214</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bryan</surname>
<given-names>CJ</given-names></string-name>. <article-title>Repetitive traumatic brain injury (or concussion) increases severity of sleep disturbance among deployed military personnel</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2013</year>;<volume>36</volume>(<issue>6</issue>):<fpage>941</fpage>–<lpage>946</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.2730</pub-id><pub-id pub-id-type="pmid">23729938</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Castriotta</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Murthy</surname>
<given-names>JN</given-names></string-name>. <article-title>Sleep disorders in patients with traumatic brain injury</article-title>. <source><italic toggle="yes">CNS Drugs</italic></source>. <year>2011</year>;<volume>25</volume>(<issue>3</issue>):<fpage>175</fpage>–<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.2165/11584870-000000000-00000</pub-id><pub-id pub-id-type="pmid">21062105</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mollayeva</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Pratt</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mollayeva</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Shapiro</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Cassidy</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Colantonio</surname>
<given-names>A</given-names></string-name>. <article-title>The relationship between insomnia and disability in workers with mild traumatic brain injury/concussion</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2016</year>;<volume>20</volume>:<fpage>157</fpage>–<lpage>166</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2015.09.008</pub-id><pub-id pub-id-type="pmid">26790723</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Frieden</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Houry</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Baldwin</surname>
<given-names>G</given-names></string-name>. <article-title>Traumatic brain injury in the United States: epidemiology and rehabilitation</article-title>. <source><italic toggle="yes">CDC NIH Rep to Congr</italic></source>. <year>2015</year>;<fpage>1</fpage>–<lpage>74</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ling</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hardy</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zetterberg</surname>
<given-names>H</given-names></string-name>. <article-title>Neurological consequences of traumatic brain injuries in sports</article-title>. <source><italic toggle="yes">Mol Cell Neurosci</italic></source>. <year>2015</year>;<volume>66</volume>:<fpage>114</fpage>–<lpage>122</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mcn.2015.03.012</pub-id><pub-id pub-id-type="pmid">25770439</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bergersen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>JØ</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Tryti</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>SI</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>A</given-names></string-name>. <article-title>A systematic literature review of psychotherapeutic treatment of prolonged symptoms after mild traumatic brain injury</article-title>. <source><italic toggle="yes">Brain Inj</italic></source>. <year>2017</year>;<volume>31</volume>(<issue>3</issue>):<fpage>279</fpage>–<lpage>289</lpage>. doi:<pub-id pub-id-type="doi">10.1080/02699052.2016.1255779</pub-id><pub-id pub-id-type="pmid">28125305</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Thomas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Greenwald</surname>
<given-names>BD</given-names></string-name>. <article-title>Nonpharmacological management of sleep disturbances after traumatic brain injury</article-title>. <source><italic toggle="yes">NeuroRehabilitation</italic></source>. <year>2018</year>;<volume>43</volume>(<issue>3</issue>):<fpage>355</fpage>–<lpage>360</lpage>. doi:<pub-id pub-id-type="doi">10.3233/NRE-182535</pub-id><pub-id pub-id-type="pmid">30347629</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Steriade</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Datta</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pare</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Oakson</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dossi</surname>
<given-names>RC</given-names></string-name>. <article-title>Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>1990</year>;<volume>10</volume>(<issue>8</issue>):<fpage>2541</fpage>–<lpage>2559</lpage>.<pub-id pub-id-type="pmid">2388079</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dittrich</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Morairty</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Warrier</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Kilduff</surname>
<given-names>TS</given-names></string-name>. <article-title>Homeostatic sleep pressure is the primary factor of activation of cortical nNOS/NK1 neurons</article-title>. <source><italic toggle="yes">Neuropsychopharmacology</italic></source>. <year>2014</year>;<volume>40</volume>(<issue>3</issue>):<fpage>632</fpage>–<lpage>639</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2014.212</pub-id><pub-id pub-id-type="pmid">25139062</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lewy</surname>
<given-names>AJ</given-names></string-name>. <article-title>Melatonin and human chronobiology</article-title>. <source><italic toggle="yes">Cold Spring Harb Symp Quant Biol</italic></source>. <year>2007</year>;<volume>72</volume>(<issue>1</issue>):<fpage>623</fpage>–<lpage>636</lpage>. doi:<pub-id pub-id-type="doi">10.1101/sqb.2007.72.055</pub-id><pub-id pub-id-type="pmid">18419322</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schwartz</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Kilduff</surname>
<given-names>TS</given-names></string-name>. <article-title>The neurobiology of sleep and wakefulness</article-title>. <source><italic toggle="yes">Psychiatr Clin North Am</italic></source>. <year>2015</year>;<volume>38</volume>(<issue>4</issue>):<fpage>615</fpage>–<lpage>644</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psc.2015.07.002</pub-id><pub-id pub-id-type="pmid">26600100</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Krueger</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Obál</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kubota</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Taishi</surname>
<given-names>P</given-names></string-name>. <article-title>The role of cytokines in physiological sleep regulation</article-title>. <source><italic toggle="yes">Ann N Y Acad Sci</italic></source>. <year>2006</year>;<volume>933</volume>(<issue>1</issue>):<fpage>211</fpage>–<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1749-6632.2001.tb05826.x</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Apergis-Schoute</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Iordanidou</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Faure</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2015</year>;<volume>35</volume>(<issue>14</issue>):<fpage>5435</fpage>–<lpage>5441</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5269-14.2015</pub-id><pub-id pub-id-type="pmid">25855162</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sinclair</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Ponsford</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rajaratnam</surname>
<given-names>SMW</given-names></string-name>. <article-title>Actigraphic assessment of sleep disturbances following traumatic brain injury</article-title>. <source><italic toggle="yes">Behav Sleep Med</italic></source>. <year>2013</year>;<volume>12</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15402002.2012.726203</pub-id><pub-id pub-id-type="pmid">23394102</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vieira</surname>
<given-names>RDCA</given-names></string-name>, <string-name><surname>Paiva</surname>
<given-names>WS</given-names></string-name>, <string-name><surname>Oliveira</surname>
<given-names>DVD</given-names></string-name>, <string-name><surname>Teixeira</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Andrade</surname>
<given-names>AFD</given-names></string-name>, <string-name><surname>Sousa</surname>
<given-names>RMCD</given-names></string-name>. <article-title>Diffuse axonal injury: epidemiology, outcome and associated risk factors</article-title>. <source><italic toggle="yes">Front Neurol</italic></source>. <year>2016</year>;<volume>7</volume>:<fpage>178</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fneur.2016.00178</pub-id><pub-id pub-id-type="pmid">27812349</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Baumann</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Werth</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Stocker</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ludwig</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bassetti</surname>
<given-names>CL</given-names></string-name>. <article-title>Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>2007</year>;<volume>130</volume>(<issue>7</issue>):<fpage>1873</fpage>–<lpage>1883</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awm109</pub-id><pub-id pub-id-type="pmid">17584779</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sullan</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Asken</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Jaffee</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Dekosky</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Bauer</surname>
<given-names>RM</given-names></string-name>. <article-title>Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy</article-title>. <source><italic toggle="yes">Neurosci Biobehav Rev</italic></source>. <year>2017</year>;<volume>84</volume>:<fpage>316</fpage>–<lpage>324</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.08.016</pub-id><pub-id pub-id-type="pmid">28859995</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mantua</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Grillakis</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mahfouz</surname>
<given-names>SH</given-names></string-name>, et al. <article-title>A systematic review and meta-analysis of sleep architecture and chronic traumatic brain injury</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2018</year>;<volume>41</volume>:<fpage>61</fpage>–<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2018.01.004</pub-id><pub-id pub-id-type="pmid">29452727</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grima</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ponsford</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rajaratnam</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Mansfield</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pase</surname>
<given-names>MP</given-names></string-name>. <article-title>Sleep disturbances in traumatic brain injury: a meta-analysis</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2016</year>;<volume>12</volume>(<issue>3</issue>):<fpage>419</fpage>–<lpage>428</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.5598</pub-id><pub-id pub-id-type="pmid">26564384</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Boone</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Sell</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Micci</surname>
<given-names>M-A</given-names></string-name>, et al. <article-title>Traumatic brain injury-induced dysregulation of the circadian clock</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2012</year>;<volume>7</volume>(<issue>10</issue>):<fpage>e46204</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0046204</pub-id><pub-id pub-id-type="pmid">23056261</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mollayeva</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mollayeva</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Colantonio</surname>
<given-names>A</given-names></string-name>. <article-title>The risk of sleep disorder among persons with mild traumatic brain injury</article-title>. <source><italic toggle="yes">Curr Neurol Neurosci Rep</italic></source>. <year>2016</year>;<volume>16</volume>(<issue>6</issue>):<fpage>55</fpage>. doi:<pub-id pub-id-type="doi">10.1007/s11910-016-0657-2</pub-id><pub-id pub-id-type="pmid">27079955</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Collen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Orr</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Lettieri</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Carter</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Holley</surname>
<given-names>AB</given-names></string-name>. <article-title>Sleep disturbances among soldiers with combat-related traumatic brain injury</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2012</year>;<volume>142</volume>(<issue>3</issue>):<fpage>622</fpage>–<lpage>630</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.11-1603</pub-id><pub-id pub-id-type="pmid">22459784</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bacyinski</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>J</given-names></string-name>. <article-title>The paravascular pathway for brain waste clearance: current understanding, significance and controversy</article-title>. <source><italic toggle="yes">Front Neuroanat</italic></source>. <year>2017</year>;<volume>11</volume>:<fpage>101</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnana.2017.00101</pub-id><pub-id pub-id-type="pmid">29163074</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Suzuki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Khoury</surname>
<given-names>S</given-names></string-name>, <string-name><surname>El-Khatib</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Individuals with pain need more sleep in the early stage of mild traumatic brain injury</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2017</year>;<volume>33</volume>:<fpage>36</fpage>–<lpage>42</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2016.06.033</pub-id><pub-id pub-id-type="pmid">28449903</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gardani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Morfiri</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Thomson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Oneill</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mcmillan</surname>
<given-names>TM</given-names></string-name>. <article-title>Evaluation of sleep disorders in patients with severe traumatic brain injury during rehabilitation</article-title>. <source><italic toggle="yes">Arch Phys Med Rehabil</italic></source>. <year>2015</year>;<volume>96</volume>(<issue>9</issue>):<fpage>1691</fpage>–<lpage>1697</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2015.05.006</pub-id><pub-id pub-id-type="pmid">26003285</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sullivan</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Edmed</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Allan</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Karlsson</surname>
<given-names>LJE</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>SS</given-names></string-name>. <article-title>Characterizing self-reported sleep disturbance after mild traumatic brain injury</article-title>. <source><italic toggle="yes">J Neurotrauma</italic></source>. <year>2015</year>;<volume>32</volume>(<issue>7</issue>):<fpage>474</fpage>–<lpage>486</lpage>. doi:<pub-id pub-id-type="doi">10.1089/neu.2013.3284</pub-id><pub-id pub-id-type="pmid">25275933</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Capaldi</surname>
<given-names>VF</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Grillakis</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>York</surname>
<given-names>CM</given-names></string-name>. <article-title>Insomnia in the military: application and effectiveness of cognitive and pharmacologic therapies</article-title>. <source><italic toggle="yes">Curr Psych Rep</italic></source>. <year>2015</year>;<volume>17</volume>(<issue>10</issue>):<fpage>85</fpage>. doi:<pub-id pub-id-type="doi">10.1007/s11920-015-0622-9</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Plantier</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Luauté</surname>
<given-names>J</given-names></string-name>. <article-title>Drugs for behavior disorders after traumatic brain injury: systematic review and expert consensus leading to french recommendations for good practice</article-title>. <source><italic toggle="yes">Ann Phys Rehabil Med</italic></source>. <year>2016</year>;<volume>59</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>57</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.rehab.2015.10.003</pub-id><pub-id pub-id-type="pmid">26797170</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wheaton</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Mathias</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Vink</surname>
<given-names>R</given-names></string-name>. <article-title>Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury</article-title>. <source><italic toggle="yes">J Clin Psychopharmacol</italic></source>. <year>2011</year>;<volume>31</volume>(<issue>6</issue>):<fpage>745</fpage>–<lpage>757</lpage>. doi:<pub-id pub-id-type="doi">10.1097/JCP.0b013e318235f4ac</pub-id><pub-id pub-id-type="pmid">22020351</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wolfe</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Sahni</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Attarian</surname>
<given-names>H</given-names></string-name>. <article-title>Sleep disorders in traumatic brain injury</article-title>. <source><italic toggle="yes">NeuroRehabilitation</italic></source>. <year>2018</year>;<volume>43</volume>(<issue>3</issue>):<fpage>257</fpage>–<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.3233/NRE-182583</pub-id><pub-id pub-id-type="pmid">30347632</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grima</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Ponsford</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Hilaire</surname>
<given-names>MAS</given-names></string-name>, <string-name><surname>Mansfield</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rajaratnam</surname>
<given-names>SM</given-names></string-name>. <article-title>Circadian melatonin rhythm following traumatic brain injury</article-title>. <source><italic toggle="yes">Neurorehabil Neural Repair</italic></source>. <year>2016</year>;<volume>30</volume>(<issue>10</issue>):<fpage>972</fpage>–<lpage>977</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1545968316650279</pub-id><pub-id pub-id-type="pmid">27221043</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kendis</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zee</surname>
<given-names>PC</given-names></string-name>. <article-title>Sleepless patient: circadian rhythm sleep–wake disorders</article-title>. In: Malhotra RK, editor. <source><italic toggle="yes">Sleepy or Sleepless</italic><italic toggle="yes">: Clinical approach to sleep patient</italic>. Basel: Springer International Publishing</source>; <year>2015</year><fpage>:133</fpage>–<lpage>149</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Abbott</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Reid</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Zee</surname>
<given-names>PC</given-names></string-name>. <article-title>Circadian rhythm sleep–wake disorders</article-title>. <source><italic toggle="yes">Psych Clin North Am</italic></source>. <year>2015</year>;<volume>38</volume>(<issue>4</issue>):<fpage>805</fpage>–<lpage>823</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psc.2015.07.012</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nguyen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mckay</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Cognitive behavior therapy to treat sleep disturbance and fatigue after traumatic brain injury: a pilot randomized controlled trial</article-title>. <source><italic toggle="yes">Arch Phys Med Rehabil</italic></source>. <year>2017</year>;<volume>98</volume>(<issue>8</issue>):<fpage>1508</fpage>–<lpage>1517</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2017.02.031</pub-id><pub-id pub-id-type="pmid">28400181</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Elliott</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Opel</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Weymann</surname>
<given-names>KB</given-names></string-name>, et al. <article-title>Sleep disturbances in traumatic brain injury: associations with sensory sensitivity</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2018</year>;<volume>14</volume>(<issue>7</issue>):<fpage>1177</fpage>–<lpage>1186</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.7220</pub-id><pub-id pub-id-type="pmid">29991430</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kaufman</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Tzischinsky</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Epstein</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Etzioni</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lavie</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pillar</surname>
<given-names>G</given-names></string-name>. <article-title>Long-term sleep disturbances in adolescents after minor head injury</article-title>. <source><italic toggle="yes">Pediatr Neurol</italic></source>. <year>2001</year>;<volume>24</volume>(<issue>2</issue>):<fpage>129</fpage>–<lpage>134</lpage>.<pub-id pub-id-type="pmid">11275462</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Valko</surname>
<given-names>PO</given-names></string-name>, <string-name><surname>Gavrilov</surname>
<given-names>YV</given-names></string-name>, <string-name><surname>Yamamoto</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Damage to histaminergic tuberomammillary neurons and other hypothalamic neurons with traumatic brain injury</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2014</year>;<volume>77</volume>(<issue>1</issue>):<fpage>177</fpage>–<lpage>182</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24298</pub-id><pub-id pub-id-type="pmid">25363332</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Duclos</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dumont</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Blais</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Rest–activity cycle disturbances in the acute phase of moderate to severe traumatic brain injury</article-title>. <source><italic toggle="yes">Neurorehabil Neural Rep</italic></source>. <year>2013</year>;<volume>28</volume>(<issue>5</issue>):<fpage>472</fpage>–<lpage>482</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1545968313517756</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wilde</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Castriotta</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Atanasov</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Masel</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Kuna</surname>
<given-names>ST</given-names></string-name>. <article-title>Cognitive impairment in patients with traumatic brain injury and obstructive sleep apnea</article-title>. <source><italic toggle="yes">Arch Phys Med Rehabil</italic></source>. <year>2007</year>;<volume>88</volume>(<issue>10</issue>):<fpage>1284</fpage>–<lpage>1288</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2007.07.012</pub-id><pub-id pub-id-type="pmid">17908570</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Brown</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Dreer</surname>
<given-names>LE</given-names></string-name>, et al. <article-title>Change in body mass index within the first-year post-injury: a VA Traumatic Brain Injury (TBI) model systems study</article-title>. <source><italic toggle="yes">Brain Inj</italic></source>. <year>2018</year>;<volume>32</volume>(<issue>8</issue>):<fpage>986</fpage>–<lpage>993</lpage>. doi:<pub-id pub-id-type="doi">10.1080/02699052.2018.1468575</pub-id><pub-id pub-id-type="pmid">29701494</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Castriotta</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>JM</given-names></string-name>. <article-title>Sleep disorders associated with traumatic brain injury</article-title>. <source><italic toggle="yes">Arch Phys Med Rehabil</italic></source>. <year>2001</year>;<volume>82</volume>(<issue>10</issue>):<fpage>1403</fpage>–<lpage>1406</lpage>. doi:<pub-id pub-id-type="doi">10.1053/apmr.2001.26081</pub-id><pub-id pub-id-type="pmid">11588744</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lequerica</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jasey</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tremont</surname>
<given-names>JNP</given-names></string-name>, <string-name><surname>Chiaravalloti</surname>
<given-names>ND</given-names></string-name>. <article-title>Pilot study on the effect of ramelteon on sleep disturbance after traumatic brain injury: preliminary evidence from a clinical trial</article-title>. <source><italic toggle="yes">Arch Phys Med Rehabil</italic></source>. <year>2015</year>;<volume>96</volume>(<issue>10</issue>):<fpage>1802</fpage>–<lpage>1809</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2015.05.011</pub-id><pub-id pub-id-type="pmid">26026580</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shan</surname>
<given-names>RSLP</given-names></string-name>, <string-name><surname>Ashworth</surname>
<given-names>NL</given-names></string-name>. <article-title>Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury</article-title>. <source><italic toggle="yes">Am J Phys Med Rehabil</italic></source>. <year>2004</year>;<volume>83</volume>(<issue>6</issue>):<fpage>421</fpage>–<lpage>427</lpage>.<pub-id pub-id-type="pmid">15166685</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ouellet</surname>
<given-names>M-C</given-names></string-name>, <string-name><surname>Morin</surname>
<given-names>CM</given-names></string-name>. <article-title>Efficacy of cognitive-behavioral therapy for insomnia associated with traumatic brain injury: a single-case experimental design</article-title>. <source><italic toggle="yes">Arch Phys Med Rehabil</italic></source>. <year>2007</year>;<volume>88</volume>(<issue>12</issue>):<fpage>1581</fpage>–<lpage>1592</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2007.09.006</pub-id><pub-id pub-id-type="pmid">18047872</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zollman</surname>
<given-names>FS</given-names></string-name>, <string-name><surname>Larson</surname>
<given-names>EB</given-names></string-name>, <string-name><surname>Wasek-Throm</surname>
<given-names>LK</given-names></string-name>, <string-name><surname>Cyborski</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Bode</surname>
<given-names>RK</given-names></string-name>. <article-title>Acupuncture for treatment of insomnia in patients with traumatic brain injury</article-title>. <source><italic toggle="yes">J Head Trauma Rehabil</italic></source>. <year>2012</year>;<volume>27</volume>(<issue>2</issue>):<fpage>135</fpage>–<lpage>142</lpage>. doi:<pub-id pub-id-type="doi">10.1097/HTR.0b013e3182051397</pub-id><pub-id pub-id-type="pmid">21386714</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
